US Stock Movement: ORIC Pharmaceuticals surges on October 15 as JPMorgan raises target price and innovative oncology drugs
Bitget异动解读2026/10/15 20:00ORIC Pharmaceuticals Surge on October 15 Explained
Keywords: JPMorgan raises target price, Innovative oncology drugs
Date unspecified, JPMorgan maintains a Buy rating and raises ORIC's target price from $23 to $26.
(Disclaimer: This content is generated by AI technology based on publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Spot platinum hits $1,620/ounce, down 0.67% intraday.
The US dollar has reached the 6.6900 level against the offshore RMB.
AI concerns outweigh inflation benefits, US dollar sees biggest single-day drop in over a month
Despite the U.S. September PPI posting its largest monthly increase in four years and retail sales exceeding expectations—factors that should have bolstered the dollar—risk aversion triggered by a sell-off in AI-related assets led to a flight to U.S. Treasuries, pushing yields lower and weighing on the dollar. As a result, the dollar fell by 0.3% on Thursday. Analysts noted that the dollar is closely linked to AI capital expenditures, and if the market grows concerned about the peak of AI investments, the dollar would be the first to take a hit.
Crypto prices
More
